Belimumab for lupus nephritis

被引：0
|
作者：
Thorley, Jennifer
机构：
来源：
LANCET RHEUMATOLOGY | 2020年 / 2卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E665 / E665
页数：1
相关论文
共 50 条
  • [21] De novo lupus nephritis in patients receiving belimumab therapy
    Parodis, I.
    Vital, E. M.
    Jonsen, A.
    Hassan, S. U.
    Leonard, D.
    Eriksson, P.
    Bengtsson, A. A.
    Gunnarsson, I.
    Ronnblom, L.
    Sjowall, C.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 41 - 42
  • [22] Urine proteomic insights from the belimumab in lupus nephritis trial
    Weeding, Emma
    Fava, Andrea
    Mohan, Chandra
    Magder, Laurence
    Goldman, Daniel
    Petri, Michelle
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [23] B-cell depletion or belimumab or voclosporin for lupus nephritis?
    Lei, Yutian
    Loutan, Jerome
    Anders, Hans-Joachim
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2021, 30 (02): : 237 - 244
  • [24] Rituximab-refractory lupus nephritis successfully treated with belimumab
    Gonzalez-Echavarri, C.
    Ugarte, A.
    Ruiz-Irastorza, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 355 - 356
  • [25] The efficacy of rituximab plus belimumab or telitacicept in refractory lupus nephritis
    Chen, Yiting
    Shi, Nan
    Lei, Xin
    Ren, Pingping
    Lan, Lan
    Chen, Liangliang
    Wang, Yaomin
    Xu, Ying
    Lin, Yuxin
    Chen, Jianghua
    Han, Fei
    RHEUMATOLOGY, 2023,
  • [26] SUCCESSFUL TREATMENT OF LUPUS NEPHRITIS WITH BELIMUMAB AND VOCLOSPORIN: A RARE CASE
    Ebrahimi, Niloufar
    Ghozloujeh, Zohreh Gholizadeh
    Momand, David
    Abdipour, Amir
    Norouzi, Sayna
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (04) : S16 - S16
  • [27] Efectiveness of belimumab in the treatment of lupus nephritis: analysis of 8 cases
    de la Rubia Navarro, Marta
    Ivorra Cortes, Jose Rafael
    Grau Garcia, Elena
    Roman Ivorra, Jose Andres
    MEDICINA CLINICA, 2022, 159 (07): : 344 - 346
  • [28] Efficacy and Safety of Belimumab in Severe Lupus Nephritis: A Retrospective SingleCenter Study
    Aierken, Ailima
    Zhuang, Jing
    Yang, Shufen
    Yalikun, Dilina
    Xu, Chengren
    Zhang, Changrong
    Tian, Xuefei
    Jiang, Hong
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [29] Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
    Furie, Richard
    Rovin, Brad H.
    Houssiau, Frederic
    Malvar, Ana
    Teng, Y. K. Onno
    Contreras, Gabriel
    Amoura, Zahir
    Yu, Xueqing
    Mok, Chi-Chiu
    Santiago, Mittermayer B.
    Saxena, Amit
    Green, Yulia
    Ji, Beulah
    Kleoudis, Christi
    Burriss, Susan W.
    Barnett, Carly
    Roth, David A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (12): : 1117 - 1128
  • [30] Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumab
    Simeoni, Monica
    Yang, Shuying
    Tompson, Debra J.
    Dimelow, Richard
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2024, 51 (03) : 289 - 301
12345